BRIEF published on 05/21/2024 at 22:05, 2 years 3 months ago Inventiva Releases First Quarter 2024 Financial Results and Business Updates Financial Results Treasury BEI Inventive NATiV3 Clinical Trials
PRESS RELEASE published on 05/21/2024 at 22:00, 2 years 3 months ago Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update Inventiva reports 2024 First Quarter Financial Information and corporate update, including cash, deposits, and clinical trial progress. Company actively seeking financing options Financial Information Deposits Clinical Trial Cash Inventiva
Published on 09/11/2026 at 23:00, 45 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 1 hour 40 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 2 hours 20 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 6 hours 45 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 15:25, 8 hours 20 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 22:15, 1 hour 30 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 hour 35 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 4 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 5 hours 30 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 16 hours 45 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 16 hours 45 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 1 day 4 hours ago Availability of the 2026 Interim Financial Report
